Abstract
Mycobacterium bovis BCG (Bacille Calmette-Guérin) is a vaccine strain used for protection against tuberculosis. Here, we announce the complete genome sequence of M. bovis strain BCG-1 (Russia). Extensive use of this strain necessitates the study of its genome stability by comparative analysis.
GENOME ANNOUNCEMENT
Bacille Calmette-Guérin (BCG), an attenuated strain of Mycobacterium bovis, was developed by Albert Calmette and Camille Guerin in 1921 as a vaccine against tuberculosis. As a result of distributing BCG throughout the world, daughter strains appeared, and one of the first strains was BCG Russia (1). It belongs to early strains and is one of the most widely used strains in the world (2). Though most of the described differences among BCG strains refer to the period before the worldwide use of lyophilized vaccine, Wada et al. (3) have shown that mutations in vaccine strains obtained by various vaccine manufacturers from a single cell source over time reach detectable levels. Because of that, whole-genome sequencing and comparison of all BCG Russia strains are extremely important. Here, we report the complete genome sequence of M. bovis BCG-1, isolated from a working seed lot used by NPO Microgen (Russia) for vaccine production.
Genomic DNA was isolated according to van Embden et al (4). A whole-genome shotgun library, prepared with a GS FLX Titanium rapid library preparation it (Roche 454 Life Science, USA), was sequenced using the GS FLX sequencer (Roche 454 Life Science, USA). The obtained 369,059 reads (245,806,603 nucleotides [nt]) were used for de novo assembly with GS De Novo assembler version 2.9, resulting in 81 large contigs. Then, a mate-pair library with insert sizes of 2 to 3 kb was sequenced with the Ion Torrent PGM sequencer (Applied Biosystems, USA); 546,890 reads were obtained (114,344,250 nt), which were used for scaffolding. Eleven scaffolds were generated by SSPASE software (5).
The complete genome sequence of M. bovis BCG-1 comprised one circular chromosome comprising 4,370,705 bp with an average GC content of 65.60%. Annotation was generated with the NCBI Prokaryotic Genome Annotation Pipeline. A total of 4,078 genes were predicted. Three rRNAs and 45 tRNAs were identified in the genome.
To confirm that the sequenced genome is a strain of BCG Russia, which was previously described, characteristics of the strain were analyzed. The following previously described features of BCG Russia were found: DU2 type I (6), 2 copies of IS6110 (7), and RDRussia (8). A single-nucleotide insertion in the recA (9) gene was not found.
Nucleotide sequence accession numbers.
The genome sequence of M. bovis strain BCG-1 (Russia) was deposited in GenBank under the accession number CP013741. The version described in this paper is the first version, CP013741.1.
Funding Statement
This work was supported by grant no. 1078/14 from Microgen.
Footnotes
Citation Sotnikova EA, Shitikov EA, Malakhova MV, Kostryukova ES, Ilina EN, Atrasheuskaya AV, Ignatyev GM, Vinokurova NV, Gorbachyov VY. 2016. Complete genome sequence of Mycobacterium bovis strain BCG-1 (Russia). Genome Announc 4(2):e00182-16. doi:10.1128/genomeA.00182-16.
REFERENCES
- 1.Behr MA, Small PM. 1999. A historical and molecular phylogeny of BCG strains. Vaccine 17:915–922. doi: 10.1016/S0264-410X(98)00277-1. [DOI] [PubMed] [Google Scholar]
- 2.Ritz N, Hanekom WA, Robins-Browne R, Britton WJ, Curtis N. 2008. Influence of BCG vaccine strain on the immune response and protection against tuberculosis. FEMS Microbiol Rev 32:821–841. doi: 10.1111/j.1574-6976.2008.00118.x. [DOI] [PubMed] [Google Scholar]
- 3.Wada T, Maruyama F, Iwamoto T, Maeda S, Yamamoto T, Nakagawa I, Yamamoto S, Ohara N. 2015. Deep sequencing analysis of the heterogeneity of seed and commercial lots of the bacillus Calmette-Guerin (BCG) tuberculosis vaccine substrain Tokyo-172. Sci Rep 5:17827. doi: 10.1038/srep17827. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Van Embden JD, Cave MD, Crawford JT, Dale JW, Eisenach KD, Gicquel B, Hermans P, Martin C, McAdam R, Shinnick TM. 1993. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 31:406–409. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Boetzer M, Henkel CV, Jansen HJ, Butler D, Pirovano W. 2011. Scaffolding pre-assembled contigs using SSPACE. BioInformatics 27:578–579. doi: 10.1093/bioinformatics/btq683. [DOI] [PubMed] [Google Scholar]
- 6.Brosch R, Gordon SV, Garnier T, Eiglmeier K, Frigui W, Valenti P, Dos Santos S, Duthoy S, Lacroix C, Garcia-Pelayo C, Inwald JK, Golby P, Garcia JN, Hewinson RG, Behr MA, Quail MA, Churcher C, Barrell BG, Parkhill J, Cole ST. 2007. Genome plasticity of BCG and impact on vaccine efficacy. Proc Natl Acad Sci USA 104:5596–5601. doi: 10.1073/pnas.0700869104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Fomukong NG, Dale JW, Osborn TW, Grange JM. 1992. Use of gene probes based on the insertion sequence IS986 to differentiate between BCG vaccine strains. J Appl Bacteriol 72:126–133. doi: 10.1111/j.1365-2672.1992.tb01813.x. [DOI] [PubMed] [Google Scholar]
- 8.Mostowy S, Tsolaki AG, Small PM, Behr MA. 2003. The in vitro evolution of BCG vaccines. Vaccine 21:4270–4274. doi: 10.1016/S0264-410X(03)00484-5. [DOI] [PubMed] [Google Scholar]
- 9.Keller PM, Böttger EC, Sander P. 2008. Tuberculosis vaccine strain Mycobacterium bovis BCG Russia is a natural recA mutant. BMC Microbiol 8:120. doi: 10.1186/1471-2180-8-120. [DOI] [PMC free article] [PubMed] [Google Scholar]